194 related articles for article (PubMed ID: 21519029)
1. Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma.
Triozzi PL; Aldrich W; Singh A
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5529-35. PubMed ID: 21519029
[TBL] [Abstract][Full Text] [Related]
2. Effects of interleukin-1 receptor antagonist and chemotherapy on host-tumor interactions in established melanoma.
Triozzi PL; Aldrich W
Anticancer Res; 2010 Feb; 30(2):345-54. PubMed ID: 20332438
[TBL] [Abstract][Full Text] [Related]
3. Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines.
Ijland SA; Jager MJ; Heijdra BM; Westphal JR; Peek R
Melanoma Res; 1999 Oct; 9(5):445-50. PubMed ID: 10596910
[TBL] [Abstract][Full Text] [Related]
4. The role of interleukin 1 in growth and metastasis of human cancer xenografts.
Elaraj DM; Weinreich DM; Varghese S; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Alexander HR
Clin Cancer Res; 2006 Feb; 12(4):1088-96. PubMed ID: 16489061
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
[TBL] [Abstract][Full Text] [Related]
6. Effect of hypoxic stress on migration and characteristics of monocytes in uveal melanoma.
Bronkhorst IH; Jehs TM; Dijkgraaf EM; Luyten GP; van der Velden PA; van der Burg SH; Jager MJ
JAMA Ophthalmol; 2014 May; 132(5):614-21. PubMed ID: 24626595
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
[TBL] [Abstract][Full Text] [Related]
9. Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.
Economou MA; Andersson S; Vasilcanu D; All-Ericsson C; Menu E; Girnita A; Girnita L; Axelson M; Seregard S; Larsson O
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2337-42. PubMed ID: 18515579
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic profile of uveal melanoma.
Notting IC; Missotten GS; Sijmons B; Boonman ZF; Keunen JE; van der Pluijm G
Curr Eye Res; 2006 Sep; 31(9):775-85. PubMed ID: 16966150
[TBL] [Abstract][Full Text] [Related]
11. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
Weinreich DM; Elaraj DM; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Spiess PJ; Alexander HR
Cancer Res; 2003 Sep; 63(18):5957-61. PubMed ID: 14522922
[TBL] [Abstract][Full Text] [Related]
12. Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells.
Lefèvre G; Babchia N; Calipel A; Mouriaux F; Faussat AM; Mrzyk S; Mascarelli F
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1047-57. PubMed ID: 19029025
[TBL] [Abstract][Full Text] [Related]
13. Macrophage polarization contributes to the efficacy of an oncolytic HSV-1 targeting human uveal melanoma in a murine xenograft model.
Liu S; Zhang J; Fang S; Zhang Q; Zhu G; Tian Y; Zhao M; Liu F
Exp Eye Res; 2021 Jan; 202():108285. PubMed ID: 33039456
[TBL] [Abstract][Full Text] [Related]
14. SPARC is expressed in human uveal melanoma and its abrogation reduces tumor cell proliferation.
Maloney SC; Marshall JC; Antecka E; Orellana ME; Fernandes BF; Martins C; Castiglione E; DI Cesare S; Logan P; Burnier MN
Anticancer Res; 2009 Aug; 29(8):3059-64. PubMed ID: 19661316
[TBL] [Abstract][Full Text] [Related]
15. Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.
Economou MA; Andersson S; Vasilcanu D; All-Ericsson C; Menu E; Girnita A; Girnita L; Axelson M; Seregard S; Larsson O
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():35-41. PubMed ID: 19032680
[TBL] [Abstract][Full Text] [Related]
16. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles.
Herwig MC; Bergstrom C; Wells JR; Höller T; Grossniklaus HE
Exp Eye Res; 2013 Feb; 107():52-8. PubMed ID: 23206928
[TBL] [Abstract][Full Text] [Related]
17. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
[TBL] [Abstract][Full Text] [Related]
19. The role of RASSF1A in uveal melanoma.
Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
[TBL] [Abstract][Full Text] [Related]
20. Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma.
Nagarkatti-Gude N; Bronkhorst IH; van Duinen SG; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6748-55. PubMed ID: 22930720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
